{
    "nct_id": "NCT03317730",
    "official_title": "Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer",
    "inclusion_criteria": "* Histologically confirmed locally advanced cancer of mucosa of the head and neck.\n* Eligible subsites will include nasal cavity, paranasal sinuses, nasopharynx, oropharynx, oral cavity, major salivary glands, oropharynx, larynx, hypopharynx, cervical esophagus, or unknown primary site with lymph node metastases.\n* Clinical or pathologic stage III-IV\n* Scheduled to receive RT with curative intent with the expectation that some portion of the mucosa of the upper aerodigestive tract will receive a dose of at least 50 Gray.\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2.\n* Age > 19 years\n* Subjects given written informed consent\nHealthy volunteers allowed\nMust have minimum age of 19 Years",
    "exclusion_criteria": "-",
    "miscellaneous_criteria": ""
}